S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
15 A.I. Trading Opportunities a Day (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
15 A.I. Trading Opportunities a Day (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
15 A.I. Trading Opportunities a Day (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
15 A.I. Trading Opportunities a Day (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
NASDAQ:ELEV

Elevation Oncology (ELEV) Earnings Date, Estimates & Call Transcripts

$5.02
+2.01 (+66.78%)
(As of 05/26/2023 08:46 PM ET)
Compare
Today's Range
$4.37
▼
$5.89
50-Day Range
$1.71
▼
$5.06
52-Week Range
$0.72
▼
$5.89
Volume
66.83 million shs
Average Volume
1.25 million shs
Market Capitalization
$122.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 3Estimated
Actual EPS
(Mar. 9)
-$4.09 Missed By -$3.42
Consensus EPS
(Mar. 9)
-$0.67
Last Year's Q1 EPS
(3/3/2022)
-$0.41
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ELEV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELEV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Elevation Oncology Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.24)($0.24)($0.24)
Q2 20232($0.30)($0.25)($0.28)
Q3 20232($0.25)($0.24)($0.25)
Q4 20232($0.41)($0.26)($0.34)
FY 20237($1.20)($0.99)($1.10)
Q1 20241($0.27)($0.27)($0.27)
Q2 20241($0.28)($0.28)($0.28)
Q3 20241($0.29)($0.29)($0.29)
Q4 20241($0.20)($0.20)($0.20)
FY 20244($1.04)($1.04)($1.04)

ELEV Earnings Date and Information

Elevation Oncology last announced its earnings data on March 9th, 2023. The reported ($4.09) EPS for the quarter, missing the consensus estimate of ($0.67) by $3.42. Elevation Oncology has generated ($7.34) earnings per share over the last year (($7.34) diluted earnings per share). Earnings for Elevation Oncology are expected to remain at ($1.28) per share in the coming year. Elevation Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off prior year's report dates.

Elevation Oncology Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/3/2023
(Estimated)		        
3/9/2023Q4 2022($0.67)($4.09)($3.42)($4.09)
11/3/2022Q3 2022($1.12)($1.67)($0.55)($1.67)
8/4/2022Q2 2022($0.80)($0.86)($0.06)($0.86)
5/5/2022Q1 2022($0.51)($0.74)($0.23)($0.74)
3/3/2022Q4 2021($0.59)($0.41)+$0.18($0.41)
11/11/20219/30/2021($0.38)($0.53)($0.15)($0.53)
8/12/20216/30/2021($0.38)($4.84)($4.46)($4.84)












Elevation Oncology Earnings - Frequently Asked Questions

When is Elevation Oncology's earnings date?

Elevation Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off last year's report dates. Learn more on ELEV's earnings history.

Did Elevation Oncology beat their earnings estimates last quarter?

In the previous quarter, Elevation Oncology (NASDAQ:ELEV) missed the analysts' consensus estimate of ($0.67) by $3.42 with a reported earnings per share (EPS) of ($4.09). Learn more on analysts' earnings estimate vs. ELEV's actual earnings.

How much profit does Elevation Oncology generate each year?

Elevation Oncology (NASDAQ:ELEV) has a recorded net income of -$95.08 million. ELEV has generated -$7.34 earnings per share over the last four quarters.

What is Elevation Oncology's EPS forecast for next year?

Elevation Oncology's earnings are expected to stay at ($1.28) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ELEV) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -